Geron Corporation, a Bay Area biotech company that's ramping up sales of its first commercial drug, announced on Thursday ...

Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic melanomaFive-year analysis of median progression free ...

Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

Biotech hot picks highlight stocks focused on lung disease, neurological disorders and rare conditions, with growth driven by ...

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...